Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
SelectX Pharmaceuticals logo — company profile

SelectX Pharmaceuticals

Founded 2002 United States Worcester, United States 6 employees Series B Total: $8.00M Biotechnology, Health Care +1

General Information

Company Name SelectX Pharmaceuticals
Founded Year 2002
Location United States Worcester, United States
Employees 6
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with SelectX Pharmaceuticals. To contact SelectX Pharmaceuticals, visit selectxpharm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SelectX Pharmaceuticals compare?

A PDF of SelectX Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SelectX Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SelectX Pharmaceuticals

SelectX Pharmaceuticals is a biopharmaceutical company founded in 2002 and headquartered in the United States. The company focuses on the discovery and development of small molecule antimicrobials and other therapeutics for unmet medical needs through the application of its innovative Genetic Chemistry platform. Genetic Chemistry is defining a new paradigm for drug discovery, offering significant technical and economic advantages, as well as expediency in product development. Their most advanced lead is an aminoglycoside antibiotic that addresses the rapidly emerging resistant gram-negative hospital infection market. SelectX Pharmaceuticals recently secured an $8.00M Series B investment on 23 January 2004, with backing from Inventages, Techno Venture Management, Boston University Technology Development Fund. The company operates in the Biotechnology, Health Care, and Pharmaceutical industries. With its cutting-edge technology and focus on addressing critical medical needs, the company presents an intriguing opportunity for venture capital investment.

Business keywords: biopharmaceutical, antimicrobials, therapeutics, small molecule, drug discovery, Genetic Chemistry, aminoglycoside antibiotic, resistant gram-negative infections, hospital infections, unmet medical needs, innovation, biomedical research, pharmaceutical industry

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $8.00M 3
Inventages
Inventages, Techno Venture Management +1
23 Jan 2004
Venture Round Undisclosed 1
Techno Venture Management
01 Jan 2002

SelectX Pharmaceuticals Alternatives & Competitors

View All Alternatives
SelectX Pharmaceuticals vs
Ception Therapeutics, Inc.
Ception Therapeutics, Inc. United States

Ception Therapeutics, Inc. is a biotechnology company based out of Malvern, Pennsylvania

Series C
6 employees
Biotechnology, Health Care
SelectX Pharmaceuticals vs
Prokaryotics, Inc.
Prokaryotics, Inc. United States

Antibacterial discovery organization committed to bringing forth innovative therapeutics to address...

8 employees
Biopharma, Biotechnology
SelectX Pharmaceuticals vs
Sealife PHARMA® GMBH
Sealife PHARMA® GMBH

Pioneering breakthroughs in marine biochemistry to combat drug-resistant infections and advance the...

Seed
Biotechnology, Health Care
View all alternatives

FAQ About SelectX Pharmaceuticals

SelectX Pharmaceuticals is a biopharmaceutical company that focuses on the discovery and development of small molecule antimicrobials and other therapeutics for unmet medical needs through the application of its innovative Genetic Chemistry platform. The company’s most advanced lead is an aminogl...
SelectX Pharmaceuticals was founded in 2002.
SelectX Pharmaceuticals is headquartered in Worcester, United States.
SelectX Pharmaceuticals operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on biopharmaceutical, antimicrobials, therapeutics and small molecule.
SelectX Pharmaceuticals has approximately 6 employees.
SelectX Pharmaceuticals has completed 2 funding rounds, raising a total of $8.00M. The latest funding stage is Series B.
Top alternatives and competitors to SelectX Pharmaceuticals include Ception Therapeutics, Inc., Prokaryotics, Inc., Sealife PHARMA® GMBH, Akanocure Pharmaceuticals, Inc. , Zikani Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SelectX Pharmaceuticals and Ception Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SelectX Pharmaceuticals, https://bouncewatch.com/company/selectx-pharmaceuticals, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes